MRZM (MRZM) Stock Price & Analysis
MRZM (MRZM) rose 0.00% to USD 0 as of September 8, 2026 at 14:07 UTC, according to Nexqual real-time market data.
MRZM last closed at USD 0; the session ranged USD 0.01–0.01 on volume of 1,970 shares. Market capitalization is —, with a 52-week range of USD 0–0.01 (PNK). Source: Nexqual, September 8, 2026 at 14:07 UTC.
Key Statistics (as of September 8, 2026 at 14:07 UTC)
| Price | USD 0 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 0 |
| Open | USD 0 |
| Day Range | USD 0.01 – 0.01 |
| 52-Week Range | USD 0 – 0.01 |
| Volume | 1,970 shares |
| Market Cap | — |
| Exchange | PNK |
Technical Analysis (MRZM)
Nexqual's technical model rates MRZM "BUY" based on 4 bullish and 1 bearish signals across 126 daily candles, as of September 8, 2026 at 14:07 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 100 (overbought) |
| vs SMA50 | Below (USD 0) |
| MACD | 0 (negative) |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| EMMA | Emmaus Life Sciences, Inc. | USD 0.06 | ▼ 1.63% |
| ACBM | ACRO BIOMEDICAL CO LTD | USD 0.03 | ▲ 0% |
| PBSV | Pharma-Bio Serv, Inc. | USD 0.54 | ▲ 14.89% |
| MBXBF | MICROBIX BIOSYSTEMS | USD 0.23 | ▲ 5.07% |
| CLCS | Cell Source, Inc. | USD 0.52 | ▼ 29.81% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 14:07 UTC. This page is informational and not investment advice.